메뉴 건너뛰기




Volumn 24, Issue , 2001, Pages 552-557

The WHO international drug monitoring programme

(2)  Olsson, S a   Edwards, I R a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords


EID: 0008800627     PISSN: 03786080     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0378-6080(01)80055-6     Document Type: Article
Times cited : (1)

References (6)
  • 2
    • 0029885854 scopus 로고    scopus 로고
    • Impact and credibility of the WHO adverse reaction signals
    • Fucik H Edwards IR Impact and credibility of the WHO adverse reaction signals Drug Inf J 30 1996 461 464
    • (1996) Drug Inf J , vol.30 , pp. 461-464
    • Fucik, H1    Edwards, IR2
  • 3
    • 0027980384 scopus 로고
    • New pharmacovigilance information on an old drug; an international study of spontaneous reports on digoxin
    • Lindquist M Saderson J Claesson C Imbs J-L Rohan A Edwards IR New pharmacovigilance information on an old drug; an international study of spontaneous reports on digoxin Drug Invest 8 1994 73 80
    • (1994) Drug Invest , vol.8 , pp. 73-80
    • Lindquist, M1    Saderson, J2    Claesson, C3    Imbs, J-L4    Rohan, A5    Edwards, IR6
  • 5
    • 0028049067 scopus 로고
    • Harmonisation in pharmacovigilance
    • Biriell C Edwards IR Harmonisation in pharmacovigilance Drug Saf 10 1994 93 102
    • (1994) Drug Saf , vol.10 , pp. 93-102
    • Biriell, C1    Edwards, IR2
  • 6
    • 0031903233 scopus 로고    scopus 로고
    • The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts
    • Olsson S The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety Efforts Drug Saf 19 1998 1 10
    • (1998) Drug Saf , vol.19 , pp. 1-10
    • Olsson, S1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.